Last $0.04 USD
Change Today -0.0005 / -1.27%
Volume 20.0K
MDST On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

mindesta inc (MDST) Snapshot

Open
$0.04
Previous Close
$0.04
Day High
$0.04
Day Low
$0.04
52 Week High
09/23/14 - $0.15
52 Week Low
01/30/14 - $0.0010
Market Cap
1.4M
Average Volume 10 Days
21.8K
EPS TTM
$0.03
Shares Outstanding
35.2M
EX-Date
--
P/E TM
1.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for MINDESTA INC (MDST)

Related News

No related news articles were found.

mindesta inc (MDST) Related Businessweek News

No Related Businessweek News Found

mindesta inc (MDST) Details

Mindesta Inc. develops fast dissolving drug delivery systems for the pharmaceutical industry in Canada. Its technology platform develops advanced oral delivery thin wafers infused with natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. The company is headquartered in Ottawa, Canada.

mindesta inc (MDST) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mindesta inc (MDST) Key Developments

Mindesta Inc. Announces Executive Appointments

The Board of Directors of Mindesta Inc. announced the appointment of Gilles Derome and Dr. Dana Allen as Advisory Board members of the firm - CTT Pharmaceuticals, effective immediately. Gilles Derome brings more than twenty-five years of marketing-sales and senior management experience in pharmaceuticals combined with consulting for bio-pharmaceutical companies. Through his pharmaceutical career at Sandoz/Novartis, Gilles had the opportunity to launch several products spanned over different therapeutic areas such as immunology, oncology, neurology, asthma, cardiovascular, mental health and women health. During his tenure as Head of Scientific Development, Gilles had the pre-marketing responsibility for the entire company's portfolio ensuring proper products positioning, pricing and reimbursement strategy to accelerate market penetration. Dr. Dana Allen, most recently served as Chair of the Department of Clinical Studies of the Ontario Veterinary College and in the past served as Chair of the Department of Companion Animals of the Atlantic Veterinary College.

Mindesta Inc. Announces Management Changes

Mindesta Inc. has closed on its acquisition of CTT Pharmaceuticals Inc. In connection with the acquisition of CTT Pharma, Gregory Bowes tendered his resignation as company's sole officer and director. Dr. Pankaj Modi and Dean Hanisch were appointed officers and directors of Mindesta and Dr. Allen Greenspoon was appointed a director. Dr. Pankaj Modi, serves as the company's Chief Executive Officer and as a Director. Dr. Modi received his M.D. in internal medicine (diabetology) from the Instituto de Endocrinologia Metabolismo y Reproduction, SA/University of Florida and completed a post-doctoral fellowship in neuroscience at McMaster University in Hamilton, Canada. Dean Hanisch, serves as the company's President and as a Director. Mr. Hanisch has over 15 years experience in business and finance and has worked for and served as a consultant to several public companies. Since October 2011 he has worked for Steenberg Financial as a consultant for the company's North American brokerage services. Dr. Allen Greenspoon, serves as a Director. Dr. Greenspoon has been a practicing physician specializing in obstetrics and occupational health for over 25 years working in Hamilton, Ontario. He has conducted multiple clinical research studies related to diabetes, lipids (cholesterol) management, dermatology, obesity, oncology related research and cardiovascular diseases.

Mindesta Inc. Auditor Raises 'Going Concern' Doubt

Mindesta Inc. filed its Annual on Sep 11, 2014 for the period ending Feb 28, 2014. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDST:US $0.04 USD -0.0005

MDST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDST.
View Industry Companies
 

Industry Analysis

MDST

Industry Average

Valuation MDST Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MINDESTA INC, please visit www.cttpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.